Fate Therapeutics, Inc. (FATE) revenue

Revenue · fiscal 2025
$6.65M

Fate Therapeutics, Inc. (FATE) reported revenue of $6.65M in fiscal 2025 (the year ended December 31, 2025). That is 51.2% lower than the $13.63M of fiscal 2024. Figures as of 18 Nov 2026, 05:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$6.65M
Change on fiscal 2024
−51.2%
Growth, 5 years
−26.7% a year
Growth, 10 years
+10.6% a year
Highest on record
$96.30Mfiscal 2022
Lowest on record
$971.00Kfiscal 2013
Fiscal years on record
142011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Fate Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 26.7% a year; over ten years the rate was 10.6% a year. Across the 14 fiscal years on record (2011–2025), the highest was $96.30M in fiscal 2022 and the lowest $971.00K in fiscal 2013.

History · 14 fiscal years

Revenue by fiscal year

Fate Therapeutics, Inc. revenue, year by year

Fate Therapeutics, Inc. (FATE) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$6.65M 51.2% down
2024$13.63M 78.5% down
2023$63.53M 34.0% down
2022$96.30M 72.4% up
2021$55.85M 77.7% up
2020$31.43M 194.3% up
2019$10.68M 125.3% up
2018$4.74M 15.4% up
2017$4.11M 6.7% down
2016$4.40M 81.1% up
2015$2.43M—
2013$971.00K 63.6% down
2012$2.67M 128.2% up
2011$1.17M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on FATE

Fate Therapeutics, Inc., figure by figure

Fate Therapeutics, Inc. (FATE) overview: price, valuation and scorecard

Fate Therapeutics, Inc. revenue: questions and answers

What is Fate Therapeutics, Inc.'s revenue?

Fate Therapeutics, Inc. (FATE) reported revenue of $6.65M in fiscal 2025 (the year ended December 31, 2025). That is 51.2% lower than the $13.63M of fiscal 2024.

What is the growth rate of Fate Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 26.7% a year; over ten years the rate was 10.6% a year.

What are the highest and lowest revenue figures on record for Fate Therapeutics, Inc.?

Across the 14 fiscal years on record (2011–2025), the highest was $96.30M in fiscal 2022 and the lowest $971.00K in fiscal 2013.

How is Fate Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Fate Therapeutics, Inc. (FATE) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/FATE/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.